PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 12, 2026Analytical Chemistry3 citations

Optomagnetic Viscometry for Monitoring Nanoscale Blood Coagulation Dynamics In Vitro

View Full Paper
QBQin BiYYYulin YangLSLiyang Shi

Key Points

  • The research aims to develop a method for monitoring nanoscale viscosity changes during blood coagulation.
  • Developed an optomagnetic nanorelaxometry platform
  • Analyzed Brownian relaxation dynamics of magnetic nanoparticles
  • Used a sample volume of 50 μL
  • Evaluated method with glycerol solutions and platelet-rich plasma
  • Tested clinical anticoagulants and thrombolytic agents
  • Demonstrated quantitative accuracy in measuring viscosity changes
  • Tracked dynamic viscosity during collagen gelation
  • Revealed a nonmonotonic viscosity profile during coagulation that conventional assays missed
  • Confirmed practical utility for pharmacological screening and point-of-care monitoring

Abstract

Capturing the dynamic variations of nanoscale viscosity within biological fluids is pivotal for deciphering the mechanisms of critical physiological and pathological processes, notably blood coagulation. However, this endeavor remains challenging due to the limitations of conventional techniques. Standard assays relying on bulk optical or rheological measurements lack the spatial resolution required for nanoscale viscosity analysis, failing to distinguish cascade processes in complex coagulation reactions. We present an optomagnetic nanorelaxometry platform that probes nanoscale viscosity in real time through analysis of magnetic nanoparticles' Brownian relaxation dynamics. Requiring a sample volume of 50 μL, the platform demonstrated quantitative accuracy in glycerol solutions and successfully tracked dynamic viscosity changes during collagen gelation. Most notably, during platelet-rich plasma coagulation, our platform revealed a nonmonotonic viscosity profile inaccessible to conventional assays, suggesting a novel methodological perspective on coagulation mechanisms. Evaluation with clinical anticoagulants and a thrombolytic agent further confirmed its practical utility, underscoring the platform's potential for pharmacological screening and point-of-care coagulation monitoring with nanoscale resolution.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bi et al. (2026) studied this question.

synapsesocial.com/papers/69db361c4fe01fead37c470ahttps://doi.org/10.1021/acs.analchem.5c07403
Ask AI
Helpful
Bookmark
Share
View Full Paper